Navigation Links
China Sky One Medical Obtains Production Licenses for Thirteen New Medical Products
Date:4/7/2011

HARBIN, China, April 7, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (NASDAQ: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that the Company, jointly with Heilongjiang Traditional Chinese Medical University ("HTCMU"), has obtained production licenses for thirteen new medical products from the Heilongjiang Food and Drug Administration ("Heilongjiang FDA") in China. These thirteen products include:No.

Product Names1

Kang Xi Eye Patch2

KangXi Dental Ulcer Membrane3

KangXi Anti-virus Mouthwash4

KangXi Dental Ulcer Mouthwash5

KangXi Snore Stopper6

Kang Xi Periarthritis Shoulder Patch7

KangXi Cervical Vertebrae Patch8

KangXi Lumbar Patch9

KangXi Rheumatoid Patch10

KangXi Hyperostosis Patch11

BiChang Nose Patch12

YuFu Scar Patch13

YuFu Wound Healing PatchChina Sky One is preparing for trial production and searching for the best production process for these thirteen products, which the Company expects to introduce to the market as soon as the fourth quarter of 2011.

"We are pleased to obtain production licenses for these exciting new products, which as a group we believe will contribute materially to China Sky One's revenue and net income in 2012," commented Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "As these mostly external-use medical products dovetail well with our existing production facilities and sales network, we expect to manufacture and sell them efficiently without much extra effort. Going forward, we plan to strengthen our partnership with research institutions such as HTCMU, leveraging their R&D capabilities to enrich our product portfolio and improve the Company's profitability."

About China Sky One Medical, Inc. China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company, Harbin First Bio-Engineering Company Limited, Heilongjiang Tianlong Pharmaceutical, Inc. and Peng Lai Jin Chuang Pharmaceutical Company, the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the Company's brand recognition and product quality. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, the potential of introduced or undetected flaws and defects in products, consumer acceptance of new products to be launched, including the thirteen new medical products for which the Company received production license approval from Heilongjiang FDA, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

Investor Relations Contact:China Sky One Medical

CCG Investor RelationsHongyu Pan, CFO

Crocker Coulson, PresidentEmail: ir@cski.com.cn

Tel: +1-646-213-1915Email: crocker.coulson@ccgir.comWebsite: www.ccgirasia.com Mabel Zhang, Vice PresidentTel: +1-310-954-1353Email: mabel.zhang@ccgir.com
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray Medical to Exhibit New Products at 65th China International Medical Equipment Fair
2. Major China Regenerative Medicine Company Adopts ThermoGenesis Cord Blood Stem Cell Processing And Storage Technologies
3. Chinese Army Established the First Chest Pain Rescue Network in China by Using IVT mHealth System
4. Sinovac Participates in UBS Greater China Healthcare Corporate Day
5. China Medicine Corporation Files Extension for Fiscal 2010 Form 10-K Filing
6. China Medicine Corporation Voluntarily Withdraws Application for Nasdaq Listing
7. Varian Medical Systems to Exhibit New TrueBeam™ System for Image-Guided Radiotherapy at ChinaMed Exhibition in Beijing
8. 2011 China-Africa Brightness Action Launched in Beijing
9. China-Biotics Wins First US Customer
10. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China
11. Video from Novo Nordisk A/S available on thenewsmarket.com: Novo Nordisk Receives Approval for Victoza in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... 2016 Global Paclitaxel Market 2016 ... 12 companies and the Paclitaxel analysis in this study ... industry and its players. This is the ... details the current state of the industry while providing ... applications and industry chain structure. The Paclitaxel market analysis ...
(Date:5/23/2016)... , May 23, 2016 ... Size, Share, Development, Growth and Demand Forecast to ... and Other), by Application (Drug Discovery and Development, ... Users (Pharmaceuticals, Life Science and Biotechnology, Academic and ... Market Research, the global mass spectrometry market ...
(Date:5/23/2016)... 2016 Non-invasive diagnostic test realizes ... diseases; ,Technology to be presented at Yissum’s booth, at ... Development Company of the Hebrew University of Jerusalem ... with Aurum Ventures MKI, the technology investment arm of ... diagnostic approach for early detection of multiple diseases by ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... WaterAid launched the #perioddrama campaign to mark Menstrual ... 1 billion women around the world who do not have access to a toilet, even ... US about their dread of #perioddrama. The (sometimes hilarious) results help shine a light on ...
(Date:5/24/2016)... ... May 24, 2016 , ... Local chiropractor Dr. Jason ... 21, 2016. Dr. Gerard, who holds a Doctorate of Chiropractic and Bachelors of ... health and wellness in Third World countries where resources are limited. , ChiroMission ...
(Date:5/24/2016)... ... May 24, 2016 , ... The Dream Builders Project, ... and other necessities to Eunime Orphanage in Tijuana, Mexico on Saturday, May 21st. The ... at Peter Piper Pizza. , More than 15 volunteers traveled from Los Angeles ...
(Date:5/24/2016)... ... 2016 , ... The old expression “a pain in the neck” takes on ... misunderstood, whiplash should be swiftly diagnosed and treated if those affected want to quickly ... Spine Center . , So named because of the whip-like, rapid back-and-forth neck ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... After graduating ... He spent the next decade in hospitals, on medication, living on Social Security disability ... at the Illness and How I Beat It!” (published by Balboa Press), Alexander shares ...
Breaking Medicine News(10 mins):